As of November 2024, Lumosa Therapeutics has a market cap of $1.32B. This makes Lumosa Therapeutics the world's 6636th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $817.57M | 132.06% |
2023 | $352.30M | 73.35% |
2022 | $203.23M | -2.11% |
2021 | $207.62M | 14.18% |
2020 | $181.83M | 2.47% |
2019 | $177.44M | 12.97% |
2018 | $157.07M | 3.22% |
2017 | $152.17M | -33.33% |
2016 | $228.25M | -47.32% |
2015 | $433.23M | - |